European Respiratory Society (ERS) 2022 | Barcelona

Presentation highlights from the ADVENT symposia at the ERS 2022 congress in Barcelona, Spain.

PhD

Oscar Palomares +1 more

Past event

4September2022

Location

Barcelona Spain

Description

Join a panel of global experts as they explore precision medicine for adults with severe asthma. First, Oscar Palomares, PhD, and Enrico Heffler, MD, PhD, will describe the use of type 2 inflammatory biomarkers and the efficacy of long-term biologics for patients with severe asthma. Then, Prof. Heffler will highlight the need to decrease oral corticosteroid (OCS) dependency in patients with severe asthma and the role of biologics.

Location

Barcelona Spain

Speakers

Allergy/Immunology

PhD

Oscar Palomares

Complutense University of Madrid

Allergy/Immunology

MD, PhD

Enrico Heffler

Associate Professor of Internal Medicine and Consultant | Personalized Medicine Asthma and Allergy Unit, Humanitas University, Milan, Italy

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region